Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes

Stan J. J. Brouns(National Center for Biotechnology Information), Matthijs M. Jore(National Center for Biotechnology Information), Magnus Lundgren(National Center for Biotechnology Information), Edze R. Westra(National Center for Biotechnology Information), Rik J. H. Slijkhuis(National Center for Biotechnology Information), Ambrosius P. Snijders(National Center for Biotechnology Information), Mark J. Dickman(National Center for Biotechnology Information), Kira S. Makarova(National Center for Biotechnology Information), Eugene V. Koonin(National Center for Biotechnology Information), John van der Oost(National Center for Biotechnology Information)
Science
August 14, 2008
Cited by 2,610Open Access
Full Text

Abstract

Prokaryotes acquire virus resistance by integrating short fragments of viral nucleic acid into clusters of regularly interspaced short palindromic repeats (CRISPRs). Here we show how virus-derived sequences contained in CRISPRs are used by CRISPR-associated (Cas) proteins from the host to mediate an antiviral response that counteracts infection. After transcription of the CRISPR, a complex of Cas proteins termed Cascade cleaves a CRISPR RNA precursor in each repeat and retains the cleavage products containing the virus-derived sequence. Assisted by the helicase Cas3, these mature CRISPR RNAs then serve as small guide RNAs that enable Cascade to interfere with virus proliferation. Our results demonstrate that the formation of mature guide RNAs by the CRISPR RNA endonuclease subunit of Cascade is a mechanistic requirement for antiviral defense.


Related Papers

No related papers found

Powered by citation graph analysis